SCHEMBL22750896

SCHEMBL22750896

O=C(O)CCC(=O)OCC1O[C@@H](OCc2ccccc2)C(OCc2ccccc2)C(OCc2ccccc2)[C@@H]1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 9/20 0.48
▸ CDC25B P30305 8/20 0.48
▸ PTPN2 P17706 5/20 0.48
▸ PTPN11 Q06124 5/20 0.48
▸ PTPN6 P29350 4/20 0.48
▸ TNF P01375 1/20 0.47
▸ NT5E P21589 1/20 0.46
▸ SSTR1 P30872 1/20 0.45
▸ SSTR2 P30874 1/20 0.45
▸ SSTR4 P31391 1/20 0.45
▸ SSTR3 P32745 1/20 0.45
▸ SSTR5 P35346 1/20 0.45
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ FGF1 P05230 2/20 0.42
▸ FGF2 P09038 2/20 0.42
▸ VEGFA P15692 2/20 0.42
▸ HPSE Q9Y251 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL990249 1.00 PTPN1 (0.48) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL19479697 0.92 PTPN1 (0.48) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL38652098 0.89 PTPN1 (0.49) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL30052037 0.85 NT5E (0.53) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL29410626 0.83 PTPN1 (0.43) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL29410628 0.81 PTPN1 (0.56) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL6552379 0.81 PTPN1 (0.50) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL25084155 0.81 PTPN1 (0.49) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL5328922 0.79 SSTR1 (0.52) PTPN1CDC25BPTPN2PTPN11PTPN6
SCHEMBL29410617 0.79 PTPN1 (0.42) PTPN1CDC25BPTPN2PTPN11PTPN6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3231804-B1 COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS MASSACHUSETTS GEN HOSPITAL (US) 2021-03-03 — — EP disclosed
US-10857247-B2 Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders THE GENERAL HOSPITAL CORPORATION (US) 2020-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10857247-B2 Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders APP, PSEN1, PSEN2 PTPN1 4606/4885CDC25B 4682/4885PTPN2 4656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback